Home > > > > > Report Detail

Global Glucagon Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 05-Sep-2022
No. of pages: 102
Inquire Before Buying

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Glucagon market is projected to reach US$ 845.7 million by 2028 from an estimated US$ 592.8 million in 2022, at a CAGR of 6.1% during 2023 and 2028.

Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Glucagon, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Glucagon.

The Glucagon market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Glucagon market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Glucagon manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Novo Nordisk

- Eli Lilly

- Fresenius Kabi

- Torrent Labs

- Taj Pharmaceuticals

- Xeris Pharmaceuticals

Product Type Insights

Global markets are presented by Glucagon type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Glucagon are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Glucagon Segment by Type

- Inject Glucagon

- Nasal Glucagon

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Glucagon market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Glucagon market.

Glucagon Segment by Application

- Emergency Kits

- General Use

- Diagnostic & Motility

- Cardiogenic Shock

- Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Glucagon market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Glucagon and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Glucagon industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Glucagon Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Glucagon Product Introduction
1.2 Market by Type
1.2.1 Global Glucagon Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Market by Application
1.3.1 Global Glucagon Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Glucagon Market Size Estimates and Forecasts
2.1.1 Global Glucagon Revenue 2017-2028
2.1.2 Global Glucagon Sales 2017-2028
2.2 Glucagon Market Size by Region: 2022 Versus 2028
2.3 Glucagon Sales by Region (2017-2028)
2.3.1 Global Glucagon Sales by Region: 2017-2022
2.3.2 Global Glucagon Sales Forecast by Region (2023-2028)
2.3.3 Global Glucagon Sales Market Share by Region (2017-2028)
2.4 Glucagon Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Glucagon Revenue by Region: 2017-2022
2.4.2 Global Glucagon Revenue Forecast by Region (2023-2028)
2.4.3 Global Glucagon Revenue Market Share by Region (2017-2028)
3 Global Glucagon by Manufacturers
3.1 Global Top Glucagon Manufacturers by Sales
3.1.1 Global Glucagon Sales by Manufacturer (2017-2022)
3.1.2 Global Glucagon Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Glucagon Manufacturers by Revenue
3.2.1 Global Glucagon Revenue by Manufacturer (2017-2022)
3.2.2 Global Glucagon Revenue Share by Manufacturer (2017-2022)
3.3 Global Glucagon Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Glucagon Manufacturers Covered: Ranking by Revenue
3.4.2 Global Glucagon Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Glucagon Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Glucagon Manufacturing Base Distribution, Product Type
3.5.1 Glucagon Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Glucagon Product Type
3.5.3 Date of International Manufacturers Enter into Glucagon Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Novo Nordisk
4.1.1 Novo Nordisk Corporation Information
4.1.2 Novo Nordisk Description, Business Overview
4.1.3 Novo Nordisk Glucagon Products Offered
4.1.4 Novo Nordisk Glucagon Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Novo Nordisk Glucagon Sales by Product in 2021
4.1.6 Novo Nordisk Glucagon Sales by Application in 2021
4.1.7 Novo Nordisk Glucagon Sales by Geographic Area in 2021
4.1.8 Novo Nordisk Recent Developments
4.2 Eli Lilly
4.2.1 Eli Lilly Corporation Information
4.2.2 Eli Lilly Description, Business Overview
4.2.3 Eli Lilly Glucagon Products Offered
4.2.4 Eli Lilly Glucagon Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Eli Lilly Glucagon Sales by Product in 2021
4.2.6 Eli Lilly Glucagon Sales by Application in 2021
4.2.7 Eli Lilly Glucagon Sales by Geographic Area in 2021
4.2.8 Eli Lilly Recent Developments
4.3 Fresenius Kabi
4.3.1 Fresenius Kabi Corporation Information
4.3.2 Fresenius Kabi Description, Business Overview
4.3.3 Fresenius Kabi Glucagon Products Offered
4.3.4 Fresenius Kabi Glucagon Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Fresenius Kabi Glucagon Sales by Product in 2021
4.3.6 Fresenius Kabi Glucagon Sales by Application in 2021
4.3.7 Fresenius Kabi Glucagon Sales by Geographic Area in 2021
4.3.8 Fresenius Kabi Recent Developments
4.4 Torrent Labs
4.4.1 Torrent Labs Corporation Information
4.4.2 Torrent Labs Description, Business Overview
4.4.3 Torrent Labs Glucagon Products Offered
4.4.4 Torrent Labs Glucagon Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Torrent Labs Glucagon Sales by Product in 2021
4.4.6 Torrent Labs Glucagon Sales by Application in 2021
4.4.7 Torrent Labs Glucagon Sales by Geographic Area in 2021
4.4.8 Torrent Labs Recent Developments
4.5 Taj Pharmaceuticals
4.5.1 Taj Pharmaceuticals Corporation Information
4.5.2 Taj Pharmaceuticals Description, Business Overview
4.5.3 Taj Pharmaceuticals Glucagon Products Offered
4.5.4 Taj Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Taj Pharmaceuticals Glucagon Sales by Product in 2021
4.5.6 Taj Pharmaceuticals Glucagon Sales by Application in 2021
4.5.7 Taj Pharmaceuticals Glucagon Sales by Geographic Area in 2021
4.5.8 Taj Pharmaceuticals Recent Developments
4.6 Xeris Pharmaceuticals
4.6.1 Xeris Pharmaceuticals Corporation Information
4.6.2 Xeris Pharmaceuticals Description, Business Overview
4.6.3 Xeris Pharmaceuticals Glucagon Products Offered
4.6.4 Xeris Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Xeris Pharmaceuticals Glucagon Sales by Product in 2021
4.6.6 Xeris Pharmaceuticals Glucagon Sales by Application in 2021
4.6.7 Xeris Pharmaceuticals Glucagon Sales by Geographic Area in 2021
4.6.8 Xeris Pharmaceuticals Recent Development
5 Breakdown Data by Type
5.1 Global Glucagon Sales by Type (2017-2028)
5.1.1 Global Glucagon Sales by Type (2017-2022)
5.1.2 Global Glucagon Sales Forecast by Type (2023-2028)
5.1.3 Global Glucagon Sales Market Share by Type (2017-2028)
5.2 Global Glucagon Revenue Forecast by Type (2017-2028)
5.2.1 Global Glucagon Revenue by Type (2017-2022)
5.2.2 Global Glucagon Revenue Forecast by Type (2023-2028)
5.2.3 Global Glucagon Revenue Market Share by Type (2017-2028)
5.3 Glucagon Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Glucagon Sales by Application (2017-2028)
6.1.1 Global Glucagon Sales by Application (2017-2022)
6.1.2 Global Glucagon Sales Forecast by Application (2023-2028)
6.1.3 Global Glucagon Sales Market Share by Application (2017-2028)
6.2 Global Glucagon Revenue Forecast by Application (2017-2028)
6.2.1 Global Glucagon Revenue by Application (2017-2022)
6.2.2 Global Glucagon Revenue Forecast by Application (2023-2028)
6.2.3 Global Glucagon Revenue Market Share by Application (2017-2028)
6.3 Glucagon Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Glucagon Market Size YoY Growth 2017-2028
7.2 North America Glucagon Market Facts & Figures by Country
7.2.1 North America Glucagon Sales by Country (2017-2028)
7.2.2 North America Glucagon Revenue by Country (2017-2028)
7.3 North America Glucagon Sales by Type
7.4 North America Glucagon Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Glucagon Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Glucagon Market Facts & Figures by Region
8.2.1 Asia-Pacific Glucagon Sales by Region (2017-2028)
8.2.2 Asia-Pacific Glucagon Revenue by Region (2017-2028)
8.3 Asia-Pacific Glucagon Sales by Type
8.4 Asia-Pacific Glucagon Sales by Application
9 Europe
9.1 Europe Glucagon Market Size YoY Growth 2017-2028
9.2 Europe Glucagon Market Facts & Figures by Country
9.2.1 Europe Glucagon Sales by Country (2017-2028)
9.2.2 Europe Glucagon Revenue by Country (2017-2028)
9.3 Europe Glucagon Sales by Type
9.4 Europe Glucagon Sales by Application
10 Latin America
10.1 Latin America Glucagon Market Size YoY Growth 2017-2028
10.2 Latin America Glucagon Market Facts & Figures by Country
10.2.1 Latin America Glucagon Sales by Country (2017-2028)
10.2.2 Latin America Glucagon Revenue by Country (2017-2028)
10.3 Latin America Glucagon Sales by Type
10.4 Latin America Glucagon Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Glucagon Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Glucagon Market Facts & Figures by Country
11.2.1 Middle East and Africa Glucagon Sales by Country (2017-2028)
11.2.2 Middle East and Africa Glucagon Revenue by Country (2017-2028)
11.3 Middle East and Africa Glucagon Sales by Type
11.4 Middle East and Africa Glucagon Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Glucagon Supply Chain Analysis
12.2 Glucagon Key Raw Materials and Upstream Suppliers
12.3 Glucagon Clients Analysis
12.4 Glucagon Sales Channel and Sales Model Analysis
12.4.1 Glucagon Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Glucagon Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Glucagon Distributors
13 Market Dynamics
13.1 Glucagon Industry Trends
13.2 Glucagon Market Drivers
13.3 Glucagon Market Challenges
13.4 Glucagon Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Glucagon Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Inject Glucagon
Table 3. Major Manufacturers of Nasal Glucagon
Table 4. Global Glucagon Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Glucagon Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 6. Global Glucagon Sales by Region (2017-2022) & (K MT)
Table 7. Global Glucagon Sales Forecast by Region (2023-2028) & (K MT)
Table 8. Global Glucagon Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Glucagon Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 10. Global Glucagon Sales by Manufacturer (2017-2022) & (K MT)
Table 11. Global Glucagon Sales Share by Manufacturer (2017-2022)
Table 12. Glucagon Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 13. Glucagon Revenue Share by Manufacturer (2017-2022)
Table 14. Key Manufacturers Glucagon Price (2017-2022) & (USD/MT)
Table 15. Ranking of Global Top Glucagon Manufacturers by Revenue (US$ Million) in 2021
Table 16. Global Glucagon Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 17. Global Glucagon by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucagon as of 2021)
Table 18. Glucagon Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Glucagon Product Type
Table 20. Date of International Manufacturers Enter into Glucagon Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Novo Nordisk Corporation Information
Table 23. Novo Nordisk Description and Business Overview
Table 24. Novo Nordisk Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 25. Novo Nordisk Glucagon Product
Table 26. Novo Nordisk Glucagon Sales Proportion of Glucagon by Product in 2021
Table 27. Novo Nordisk Glucagon Sales Proportion of Glucagon by Application in 2021
Table 28. Novo Nordisk Glucagon Sales Proportion of Glucagon by Geographic Area in 2021
Table 29. Novo Nordisk Recent Development
Table 30. Eli Lilly Corporation Information
Table 31. Eli Lilly Description and Business Overview
Table 32. Eli Lilly Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 33. Eli Lilly Glucagon Product
Table 34. Eli Lilly Glucagon Sales Proportion of Glucagon by Product in 2021
Table 35. Eli Lilly Glucagon Sales Proportion of Glucagon by Application in 2021
Table 36. Eli Lilly Glucagon Sales Proportion of Glucagon by Geographic Area in 2021
Table 37. Eli Lilly Recent Development
Table 38. Fresenius Kabi Corporation Information
Table 39. Fresenius Kabi Description and Business Overview
Table 40. Fresenius Kabi Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 41. Fresenius Kabi Glucagon Product
Table 42. Fresenius Kabi Glucagon Sales Proportion of Glucagon by Product in 2021
Table 43. Fresenius Kabi Glucagon Sales Proportion of Glucagon by Application in 2021
Table 44. Fresenius Kabi Glucagon Sales Proportion of Glucagon by Geographic Area in 2021
Table 45. Fresenius Kabi Recent Development
Table 46. Torrent Labs Corporation Information
Table 47. Torrent Labs Description and Business Overview
Table 48. Torrent Labs Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 49. Torrent Labs Glucagon Product
Table 50. Torrent Labs Glucagon Sales Proportion of Glucagon by Product in 2021
Table 51. Torrent Labs Glucagon Sales Proportion of Glucagon by Application in 2021
Table 52. Torrent Labs Glucagon Sales Proportion of Glucagon by Geographic Area in 2021
Table 53. Torrent Labs Recent Development
Table 54. Taj Pharmaceuticals Corporation Information
Table 55. Taj Pharmaceuticals Description and Business Overview
Table 56. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 57. Taj Pharmaceuticals Glucagon Product
Table 58. Taj Pharmaceuticals Glucagon Sales Proportion of Glucagon by Product in 2021
Table 59. Taj Pharmaceuticals Glucagon Sales Proportion of Glucagon by Application in 2021
Table 60. Taj Pharmaceuticals Glucagon Sales Proportion of Glucagon by Geographic Area in 2021
Table 61. Taj Pharmaceuticals Recent Development
Table 62. Xeris Pharmaceuticals Corporation Information
Table 63. Xeris Pharmaceuticals Description and Business Overview
Table 64. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Xeris Pharmaceuticals Glucagon Product
Table 66. Xeris Pharmaceuticals Glucagon Sales Proportion of Glucagon by Product in 2021
Table 67. Xeris Pharmaceuticals Glucagon Sales Proportion of Glucagon by Application in 2021
Table 68. Xeris Pharmaceuticals Glucagon Sales Proportion of Glucagon by Geographic Area in 2021
Table 69. Global Glucagon Sales by Type (2017-2022) & (K MT)
Table 70. Global Glucagon Sales Forecast by Type (2023-2028) & (K MT)
Table 71. Global Glucagon Revenue by Type (2017-2022) & (US$ Million)
Table 72. Global Glucagon Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 73. Global Glucagon Sales by Application (2017-2022) & (K MT)
Table 74. Global Glucagon Sales Forecast by Application (2023-2028) & (K MT)
Table 75. Global Glucagon Revenue by Application (2017-2022) & (US$ Million)
Table 76. Global Glucagon Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 77. North America Glucagon Sales by Country (2017-2022) & (K MT)
Table 78. North America Glucagon Sales by Country (2023-2028) & (K MT)
Table 79. North America Glucagon Revenue by Country (2017-2022) & (US$ Million)
Table 80. North America Glucagon Revenue by Country (2023-2028) & (US$ Million)
Table 81. North America Glucagon Sales by Type (2017-2022) & (K MT)
Table 82. North America Glucagon Sales by Application (2017-2022) & (K MT)
Table 83. Asia-Pacific Glucagon Sales by Region (2017-2022) & (K MT)
Table 84. Asia-Pacific Glucagon Sales by Region (2023-2028) & (K MT)
Table 85. Asia-Pacific Glucagon Revenue by Region (2017-2028) & (US$ Million)
Table 86. Asia-Pacific Glucagon Revenue by Region (2023-2028) & (US$ Million)
Table 87. Asia-Pacific Glucagon Sales by Type (2017-2022) & (K MT)
Table 88. Asia-Pacific Glucagon Sales by Application (2017-2022) & (K MT)
Table 89. Europe Glucagon Sales by Country (2017-2022) & (K MT)
Table 90. Europe Glucagon Sales by Country (2023-2028) & (K MT)
Table 91. Europe Glucagon Revenue by Country (2017-2022) & (US$ Million)
Table 92. Europe Glucagon Revenue by Country (2023-2028) & (US$ Million)
Table 93. Europe Glucagon Sales by Type (2017-2022) & (K MT)
Table 94. Europe Glucagon Sales by Application (2017-2022) & (K MT)
Table 95. Latin America Glucagon Sales by Country (2017-2022) & (K MT)
Table 96. Latin America Glucagon Sales by Country (2023-2028) & (K MT)
Table 97. Latin America Glucagon Revenue by Country (2017-2022) & (US$ Million)
Table 98. Latin America Glucagon Revenue by Country (2023-2028) & (US$ Million)
Table 99. Latin America Glucagon Sales by Type (2017-2022) & (K MT)
Table 100. Latin America Glucagon Sales by Application (2017-2022) & (K MT)
Table 101. Middle East and Africa Glucagon Sales by Country (2017-2022) & (K MT)
Table 102. Middle East and Africa Glucagon Sales by Country (2023-2028) & (K MT)
Table 103. Middle East and Africa Glucagon Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Glucagon Revenue by Country (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Glucagon Sales by Type (2017-2022) & (K MT)
Table 106. Middle East and Africa Glucagon Sales by Application (2017-2022) & (K MT)
Table 107. Glucagon Key Raw Materials, Industry Status and Trend
Table 108. Glucagon Key Raw Materials and Upstream Suppliers
Table 109. Glucagon Clients Status and Trend
Table 110. Glucagon Typical Clients
Table 111. Glucagon Distributors
Table 112. Glucagon Market Trends
Table 113. Glucagon Market Drivers
Table 114. Glucagon Market Challenges
Table 115. Glucagon Market Restraints
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucagon Product Picture
Figure 2. Global Glucagon Sales Market Share by Type in 2021 & 2028
Figure 3. Inject Glucagon Product Picture
Figure 4. Nasal Glucagon Product Picture
Figure 5. Global Glucagon Sales Market Share by Application in 2021 & 2028
Figure 6. Emergency Kits Examples
Figure 7. General Use Examples
Figure 8. Diagnostic & Motility Examples
Figure 9. Cardiogenic Shock Examples
Figure 10. Others Examples
Figure 11. Glucagon Report Years Considered
Figure 12. Global Glucagon Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Glucagon Market Size 2017-2028 (US$ Million)
Figure 14. Global Glucagon Sales 2017-2028 (K MT)
Figure 15. Global Glucagon Market Size Market Share by Region: 2022 Versus 2028
Figure 16. Global Glucagon Sales Market Share Forecast by Region (2017-2028)
Figure 17. Global Glucagon Revenue Market Share by Region (2017-2028)
Figure 18. Global Glucagon Sales Share by Manufacturer in 2021
Figure 19. Glucagon Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Glucagon Sales Market Share Forecast by Type (2017-2028)
Figure 21. Global Glucagon Revenue Market Share Forecast by Type (2017-2028)
Figure 22. Glucagon Average Selling Price (ASP) by Type (2017-2022) & (USD/MT)
Figure 23. Global Glucagon Sales Market Share Forecast by Application (2017-2028)
Figure 24. Global Glucagon Revenue Market Share Forecast by Application (2017-2028)
Figure 25. Glucagon Average Selling Price (ASP) by Application (2017-2022) & (USD/MT)
Figure 26. North America Glucagon Revenue 2017-2028 (US$ Million)
Figure 27. North America Glucagon Sales Market Share by Type (2017-2022)
Figure 28. North America Glucagon Sales Market Share by Application (2017-2022)
Figure 29. Asia-Pacific Glucagon Revenue 2017-2028 (US$ Million)
Figure 30. Asia-Pacific Glucagon Sales Market Share by Region (2017-2028)
Figure 31. Asia-Pacific Glucagon Revenue Market Share by Region (2017-2028)
Figure 32. Asia-Pacific Glucagon Sales Market Share by Type (2017-2022)
Figure 33. Asia-Pacific Glucagon Sales Market Share by Application (2017-2022)
Figure 34. Europe Glucagon Revenue Growth Rate 2017-2028 (US$ Million)
Figure 35. Europe Glucagon Sales Market Share by Country (2017-2028)
Figure 36. Europe Glucagon Revenue Market Share by Country (2017-2028)
Figure 37. Europe Glucagon Sales Market Share by Type (2017-2022)
Figure 38. Europe Glucagon Sales Market Share by Application (2017-2022)
Figure 39. Latin America Glucagon Revenue Growth Rate 2017-2028 (US$ Million)
Figure 40. Latin America Glucagon Sales Market Share by Country (2017-2028)
Figure 41. Latin America Glucagon Revenue Market Share by Country (2017-2022)
Figure 42. Latin America Glucagon Sales Market Share by Type (2017-2022)
Figure 43. Latin America Glucagon Sales Market Share by Application (2017-2022)
Figure 44. Middle East and Africa Glucagon Revenue Growth Rate 2017-2028 (US$ Million)
Figure 45. Middle East and Africa Glucagon Sales Market Share by Country (2017-2028)
Figure 46. Middle East and Africa Glucagon Revenue Market Share by Country (2017-2028)
Figure 47. Middle East and Africa Glucagon Sales Market Share by Type (2017-2022)
Figure 48. Middle East and Africa Glucagon Sales Market Share by Application (2017-2022)
Figure 49. Glucagon Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Glucagon Raw Materials by Region in 2021
Figure 51. Glucagon Distribution Channels
Figure 52. Global Glucagon Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 53. Global Glucagon Percentage 2017-2028: Online Sales VS Offline Sales
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
  • Global Metformin Hydrochloride Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......
  • Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
  • Global Insulin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
  • Global Insulin API Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Glucagon Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Acarbose Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Insulin Glargine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77
    According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
  • Global Liraglutide Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103
    According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs